Linezolid is a potentially effective drug for the treatment of patients with drug-resistant tuberculosis. Among 13 patients treated for tuberculosis with linezolid in the present study, nine had treatment success and four remain on treatment. Adverse effects occurred in 11 (85%) patients, of whom three discontinued treatment because of adverse effects. The present study adds to the growing evidence supporting the efficacy of linezolid for tuberculosis, although treatment remains complicated by adverse effects. ©2013 Pulsus Group Inc. All rights reserved.
CITATION STYLE
Tse-Chang, A., Kunimoto, D., Der, E., & Ahmed, R. (2013). Assessment of linezolid efficacy, safety and tolerability in the treatment of tuberculosis: A retrospective case review. Canadian Journal of Infectious Diseases and Medical Microbiology. Hindawi Limited. https://doi.org/10.1155/2013/535616
Mendeley helps you to discover research relevant for your work.